We are live on
!
Find out more
GGHC
Gilder Gagnon Howe & Co Portfolio holdings
AUM
$8.34B
1-Year Est. Return
46.58%
This Fund
S&P 500
This Quarter
Est. Return
+31.62%
1 Year Est. Return
+46.58%
3 Year Est. Return
+191.6%
5 Year Est. Return
+200.35%
10 Year Est. Return
+3,561.44%
AUM
$9.37B
AUM Growth
+$2.3B
(+33%)
Cap. Flow
+$276M
Cap. Flow
% of AUM
2.95%
Top 10 Holdings %
Top 10 Hldgs %
28.83%
Holding
299
New
32
Increased
69
Reduced
169
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IRBT
iRobot
IRBT
|
+$79.1M |
| 2 |
Veracyte
VCYT
|
+$65.9M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$44.3M |
| 4 |
Lyft
LYFT
|
+$42.2M |
| 5 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
+$41.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$50.7M |
| 2 |
Netflix
NFLX
|
+$32.9M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$32.2M |
| 4 |
RingCentral
RNG
|
+$21.7M |
| 5 |
Etsy
ETSY
|
+$20.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.34% |
| 2 | Communication Services | 18.98% |
| 3 | Consumer Discretionary | 17.11% |
| 4 | Healthcare | 15.51% |
| 5 | Industrials | 4.17% |
Similar funds
MWM
AAF
NW
QC
VA
FT
OC
DM
Gilder Gagnon Howe & Co's Q1 2019 Portfolio in Review
As of Q1 2019, Gilder Gagnon Howe & Co held 299 positions worth $9.37B, up 33% from $7.06B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Gilder Gagnon Howe & Co's Q1 2019 filing shows 32 new, 69 increased, 169 reduced and 23 closed positions. Its largest new stake was Veracyte: 3,453,224 shares worth $86.4M. The largest sale was Adobe, an estimated $50.7M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- Gilder Gagnon Howe & Co's largest Q1 2019 buy was Veracyte: 3,453,224 shares worth $86.4M.
- Gilder Gagnon Howe & Co added most to iRobot in Q1 2019, an estimated $79.1M increase.
- Gilder Gagnon Howe & Co's biggest Q1 2019 reduction was Adobe, cutting an estimated $50.7M.
- Gilder Gagnon Howe & Co fully exited Spark Therapeutics, Inc. Common Stock in Q1 2019, selling an estimated $19.9M.
- Gilder Gagnon Howe & Co's ten largest holdings make up 29% of its $9.37B portfolio in Q1 2019.
- Gilder Gagnon Howe & Co opened 32 new positions and closed 23 in Q1 2019.
- Gilder Gagnon Howe & Co's portfolio value rose 33% quarter-over-quarter to $9.37B.
Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2019, filed 17 May 2019.